LAS VEGAS, May 30, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that the first of its patent pending proprietary agricultural indoor growing system for medical-grade cannabis has come off the production line.GrowBLOX Sciences has developed proprietary growing technology for environmentally controlled, indoor agricultural chambers. This is the first of the newest generation of GrowBLOX's that are expected to arrive at The Company's headquarters in Nevada by mid-June. The Company anticipates beginning quality control on both mechanics and its proprietary monitoring and report-building software before starting the full production line. The quality control test will be run by Chief Scientist and Botanist, Ulrich Reimann-Philipp, Ph.D.
"GrowBLOX Sciences is in an exciting phase in its development and we have positioned ourselves to move forward with our patent pending technology in order to change the way indoor growing methodologies take place. We are thrilled the fist indoor growing chamber is off the line and our Chief Scientist and Botanist is ready to begin quality control testing. From our indoor growing chambers to our monitoring and reporting systems, we believe our proprietary technology will impact the future of medical-grade products in Nevada," said GrowBLOX CEO, Craig Ellins.
As GrowBLOX Sciences awaits the arrival of its first indoor growing chamber off the production line, The Company is also awaiting approval on its licensing from Clark County, Nevada for their cultivation and dispensary licenses. The Company has applied for three licenses, one for cultivation and two for dispensaries.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
Forward-Looking Statements
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Craig Ellins
CEO, GrowBLOX Sciences, Inc.
+1-844-843-BLOX ext. 01
Photo - http://photos.prnewswire.com/prnh/20140530/92518
Photo - http://photos.prnewswire.com/prnh/20140530/92869
SOURCE GrowBLOX Sciences, Inc.
